Pascal Morel

5.5k total citations
148 papers, 2.5k citations indexed

About

Pascal Morel is a scholar working on Hematology, Management of Technology and Innovation and Epidemiology. According to data from OpenAlex, Pascal Morel has authored 148 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 34 papers in Management of Technology and Innovation and 30 papers in Epidemiology. Recurrent topics in Pascal Morel's work include Blood donation and transfusion practices (34 papers), Blood transfusion and management (23 papers) and Blood groups and transfusion (18 papers). Pascal Morel is often cited by papers focused on Blood donation and transfusion practices (34 papers), Blood transfusion and management (23 papers) and Blood groups and transfusion (18 papers). Pascal Morel collaborates with scholars based in France, Switzerland and United States. Pascal Morel's co-authors include Pierre Fenaux, Pierre Gallian, JL Laï, Pierre Tiberghien, F Bauters, J L Laï, Syria Laperche, Xavier de Lamballerie, Patrick Hervé and Georges Andreu and has published in prestigious journals such as Blood, PLoS ONE and Hepatology.

In The Last Decade

Pascal Morel

137 papers receiving 2.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pascal Morel 723 479 457 450 380 148 2.5k
J. A. J. Barbara 434 0.6× 321 0.7× 942 2.1× 529 1.2× 511 1.3× 125 2.9k
Rainer Seitz 1.2k 1.7× 160 0.3× 344 0.8× 165 0.4× 176 0.5× 127 2.4k
Margot S. Kruskall 1.1k 1.5× 145 0.3× 704 1.5× 249 0.6× 1.1k 3.0× 65 3.1k
Giancarlo M Liumbruno 455 0.6× 442 0.9× 218 0.5× 181 0.4× 382 1.0× 56 1.8k
Stefania Vaglio 567 0.8× 445 0.9× 168 0.4× 95 0.2× 452 1.2× 71 2.0k
David H. Yawn 204 0.3× 155 0.3× 728 1.6× 421 0.9× 276 0.7× 39 2.0k
Silvano Wendel 580 0.8× 158 0.3× 558 1.2× 106 0.2× 336 0.9× 71 1.6k
James P. AuBuchon 1.9k 2.6× 303 0.6× 688 1.5× 374 0.8× 2.8k 7.4× 129 5.0k
Giuliano Grazzini 382 0.5× 545 1.1× 231 0.5× 102 0.2× 341 0.9× 72 1.7k
Véronique Deneys 414 0.6× 226 0.5× 324 0.7× 52 0.1× 125 0.3× 75 2.3k

Countries citing papers authored by Pascal Morel

Since Specialization
Citations

This map shows the geographic impact of Pascal Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Morel more than expected).

Fields of papers citing papers by Pascal Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Morel. The network helps show where Pascal Morel may publish in the future.

Co-authorship network of co-authors of Pascal Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Morel. A scholar is included among the top collaborators of Pascal Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Morel. Pascal Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barlet, Valérie, Lucile Malard, Pascal Morel, et al.. (2024). New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24. Eurosurveillance. 29(21). 14 indexed citations
2.
Gallian, Pierre, Nathanaël Hozé, Paola Mariela Saba Villarroel, et al.. (2023). SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021. iScience. 26(4). 106222–106222. 1 indexed citations
3.
Richard, Pascale, Lucile Malard, Caroline Bacquet, et al.. (2023). Implementation of amotosalen plus ultraviolet A‐mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion‐transmitted infections. Vox Sanguinis. 119(3). 212–218. 7 indexed citations
4.
Pillonel, Josiane, Cécile Sommen, Julie Figoni, et al.. (2022). Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France. Vox Sanguinis. 117(12). 1411–1414. 3 indexed citations
5.
Gallian, Pierre, Valérie Barlet, Pierre Cappy, et al.. (2022). Low rate of RNAemia in blood donations collected during the first wave of COVID‐19 in France. Transfusion. 62(3). 633–640. 3 indexed citations
6.
Antona, Denise, Pascal Morel, Laure Fonteneau, et al.. (2019). Measles and rubella seroprevalence in a population of young adult blood donors, France 2013. Epidemiology and Infection. 147. e109–e109. 9 indexed citations
7.
Garraud, Olivier, Pascal Morel, Joliette Coste, Pierre Tiberghien, & Chantal Fournier‐Wirth. (2015). Transfusion sanguine : un modèle de questionnement en recherche et développement. La Presse Médicale. 44(2). 233–240. 2 indexed citations
8.
Morel, Pascal, et al.. (2013). Maîtrise du risque bactérien transfusionnel en France en 2013. Transfusion Clinique et Biologique. 20(2). 174–181. 12 indexed citations
9.
10.
11.
Morel, Pascal, et al.. (2006). Sécurité des produits sanguins labiles et parvovirus B19. Transfusion Clinique et Biologique. 13(4). 235–241. 10 indexed citations
12.
Laperche, Syria, Pascal Morel, Marianne Asso‐Bonnet, et al.. (2005). Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?. Transfusion. 45(12). 1965–1972. 45 indexed citations
13.
Rebibo, Danielle, et al.. (2001). [Blood transfusion surveillance: organization and results].. PubMed. 51(12). 1332–6. 1 indexed citations
14.
Morel, Pascal, et al.. (2000). Transfusion sanguine et risque bactérien. Transfusion Clinique et Biologique. 7. 55s–62s. 10 indexed citations
15.
Hervé, P, V. Lapierre, Pascal Morel, & Pierre Tiberghien. (1999). [What present strategies are helpful in improving transfusion safety in France?].. PubMed. 150(8). 623–30. 2 indexed citations
16.
Couroucé, Anne, Françis Barin, S. Chamaret, et al.. (1999). Tests de dépistage combiné des anticorps anti-VIH et de l'antigène p24. 18(102). 38–44. 12 indexed citations
17.
Robertson, Marjorie J., et al.. (1998). [Hepatic lesions after effective external cardiac massage--an iatrogenic complication not to be overlooked].. PubMed. 225–7.
18.
Fournier, B., Emiliano Giostra, Gilles Mentha, et al.. (1997). Three cases of liver transplantation for type I familial amyloid polyneuropathy. Transplantation Proceedings. 29(5). 2416–2417. 1 indexed citations
19.
Morel, Pascal, J Alexander-Williams, & A Rohner. (1990). Relation between flow-pressure-diameter studies in experimental stenosis of rabbit and human small bowel.. Gut. 31(8). 875–878. 18 indexed citations
20.
Fenaux, Pierre, J L Laï, Pascal Morel, et al.. (1989). Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3. Hematological Oncology. 7(4). 307–317. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. A. J. Barbara Breakdown of academic impact, for papers by Rainer Seitz Breakdown of academic impact, for papers by Margot S. Kruskall Breakdown of academic impact, for papers by Giancarlo M Liumbruno Breakdown of academic impact, for papers by Stefania Vaglio Breakdown of academic impact, for papers by David H. Yawn Breakdown of academic impact, for papers by Silvano Wendel Breakdown of academic impact, for papers by James P. AuBuchon Breakdown of academic impact, for papers by Giuliano Grazzini Breakdown of academic impact, for papers by Véronique Deneys
Rankless by CCL
2026